Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0E3OT
|
|||
Drug Name |
PMID30185082-Compound-14
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H33FN2O4
|
|||
Canonical SMILES |
CC1=CC(=C(C=C1)OCCF)C(=O)NCCCCN2CCC3=CC(=C(C=C3C2)OC)OC
|
|||
InChI |
1S/C25H33FN2O4/c1-18-6-7-22(32-13-9-26)21(14-18)25(29)27-10-4-5-11-28-12-8-19-15-23(30-2)24(31-3)16-20(19)17-28/h6-7,14-16H,4-5,8-13,17H2,1-3H3,(H,27,29)/i26-1
|
|||
InChIKey |
QVRVXSZKCXFBTE-KPVNRNJOSA-N
|
|||
CAS Number |
CAS 945992-47-2
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.